Literature DB >> 28610433

Reoperation Rates After Combined Anterior Cruciate Ligament and Anterolateral Ligament Reconstruction: A Series of 548 Patients From the SANTI Study Group With a Minimum Follow-up of 2 Years.

Mathieu Thaunat1, Gilles Clowez1, Adnan Saithna2,3, Maxime Cavalier1, Eric Choudja1, Thais D Vieira1, Jean-Marie Fayard1, Bertrand Sonnery-Cottet1.   

Abstract

BACKGROUND: Early clinical results of anterolateral ligament (ALL) reconstruction are promising, but concerns exist due to high rates of complications after other types of lateral extra-articular tenodesis. The rate of surgery after combined anterior cruciate ligament (ACL) and ALL reconstruction is not known.
PURPOSE: To determine the rate of reoperation after combined ACL and ALL reconstruction. STUDY
DESIGN: Case series; Level of evidence, 4.
METHODS: A retrospective analysis of prospectively collected data from the Scientific ACL Network International (SANTI) Study Group database was performed to include all patients who had undergone combined ACL and ALL reconstruction between January 2012 and June 2014. At the end of the study period, all patients were contacted by telephone, and the operative notes of those who stated that they had undergone reoperation were reviewed to determine the type and rates of the subsequent procedures performed. Descriptive data were analyzed for the entire patient cohort.
RESULTS: The study population comprised 548 quadruple hamstring graft (4HT)+ALL reconstructions. The mean age (±SD) was 24.3 ± 7.9 years (range, 11.9-55.7 years), and 70.3% of subjects were male. The mean duration of follow-up was 35.5 ± 8.0 months (range, 24-54 months). Seventy-two patients (13.1%) underwent ipsilateral reoperation. This comprised a total of 77 procedures. Graft revision occurred in 14 knees (2.6%) at a mean of 18.3 months (±7.4 months) after the index procedure. There were 63 reoperations for ipsilateral, non-graft rupture-related indications (meniscus, n = 30; arthrofibrosis, n = 22; removal of hardware, n = 4; deep infection, n = 3; arthroscopic lavage without infection, n = 4). The only specific complications related to the ALL procedure (n = 3) were all related to femoral hardware that required removal. In both univariate and multivariate analyses, only the presence of a medial meniscal lesion at the index procedure was significantly associated with ipsilateral reoperation (odds ratio, 2.58; 95% CI, 1.43-4.76; P = .002).
CONCLUSION: The reoperation rate after combined ACL and ALL reconstruction in this series is broadly comparable to the reoperation rate after isolated ACL reconstruction as reported in previous studies. In addition, the high rates of knee stiffness and reoperation reported in historical series of nonanatomic, lateral extra-articular tenodesis were not observed in the current series.

Entities:  

Keywords:  anterior cruciate ligament; anterolateral ligament; subsequent surgery

Mesh:

Year:  2017        PMID: 28610433     DOI: 10.1177/0363546517708982

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  18 in total

Review 1.  Anterior Cruciate Ligament Injury and the Anterolateral Complex of the Knee-Importance in Rotatory Knee Instability?

Authors:  Elan J Golan; Robert Tisherman; Kevin Byrne; Theresa Diermeier; Ravi Vaswani; Volker Musahl
Journal:  Curr Rev Musculoskelet Med       Date:  2019-12

2.  Predictive factors for failure of anterior cruciate ligament reconstruction via the trans-tibial technique.

Authors:  Seong Hwan Kim; Yong-Beom Park; Dong-Hyun Kim; Nicolas Pujol; Han-Jun Lee
Journal:  Arch Orthop Trauma Surg       Date:  2020-06-11       Impact factor: 3.067

3.  Interlinked Hamstrings for Combined Anterolateral and Anterior Cruciate Ligament Reconstruction: A Novel Technique for ALL.

Authors:  Santosh Sahanand; Ankit Jose; Ganesh Kumar; David V Rajan
Journal:  Indian J Orthop       Date:  2021-10-28       Impact factor: 1.251

4.  How to Avoid Knee Tunnel Convergence When Performing a Modified Lemaire Extra-Articular Tenodesis.

Authors:  Graeme P Hopper; Abdo El Helou; Corentin Philippe; Joao Pedro Campos; Thais Dutra Vieira; Bertrand Sonnery-Cottet
Journal:  Arthrosc Tech       Date:  2022-06-21

5.  Combined reconstruction of the anterolateral ligament in chronic ACL injuries leads to better clinical outcomes than isolated ACL reconstruction.

Authors:  Camilo Partezani Helito; Danilo Bordini Camargo; Marcel Faraco Sobrado; Marcelo Batista Bonadio; Pedro Nogueira Giglio; José Ricardo Pécora; Gilberto Luis Camanho; Marco Kawamura Demange
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-04-02       Impact factor: 4.342

6.  Combined ACL and Anterolateral Ligament Reconstruction.

Authors:  Adnan Saithna; Mathieu Thaunat; Jean Romain Delaloye; Hervé Ouanezar; Jean Marie Fayard; Bertrand Sonnery-Cottet
Journal:  JBJS Essent Surg Tech       Date:  2018-01-10

7.  Mid-term outcomes of anterior cruciate ligament reconstruction across age groups: A national database study.

Authors:  McKayla Kelly; Justin Turcotte; Dimitri Thomas; Benjamin Petre; Christina Morganti; James York; Daniel Redziniak
Journal:  J Orthop       Date:  2021-01-20

8.  Painful Palpation of the Tibial Insertion of the Anterolateral Ligament Is Concordant With Acute Anterolateral Ligament Injury.

Authors:  Jérôme Murgier; Pierre Thomas; Nicolas Reina; Rémi Sylvie; Emilie Bérard; Etienne Cavaignac
Journal:  Orthop J Sports Med       Date:  2020-06-26

9.  Clinical Outcomes After Combined Anterior Cruciate Ligament and Anterolateral Ligament Reconstruction.

Authors:  Jean-Romain Delaloye; Jozef Murar; Mauricio Gonzalez; Thiago Amaral; Vikram Kakatkar; Bertrand Sonnery-Cottet
Journal:  Tech Orthop       Date:  2017-12-25

10.  Anterolateral Ligament Reconstruction: A Possible Option in the Therapeutic Arsenal for Persistent Rotatory Instability After ACL Reconstruction.

Authors:  Camilo Partezani Helito; Adnan Saithna; Marcelo B Bonadio; Matt Daggett; Edoardo Monaco; Marco K Demange; Bertrand Sonnery-Cottet
Journal:  Orthop J Sports Med       Date:  2018-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.